FDA Clearance Tracker · P110008-S013
coflex Interlaminar Stabilization Device
Last checked: Nov 20, 2026Latest source record: Mar 31, 2021 (this decision)Source: openFDAMethods & limitations
Decided
Mar 31, 2021
Approved
Time to decision
84 days
Received Jan 6, 2021. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P110008-S013
- Device name
- coflex Interlaminar Stabilization Device
- Applicant
- Companion Spine France
- Applicant location
- Merignac Gironde
- Received
- Jan 6, 2021
- Decided
- Mar 31, 2021
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Postapproval Study Protocol
- Original approval
- P110008
Device type
- Device class
- Class III
- Specialty
- Orthopedic SurgerySpine
FDA's approval statement
As written in FDA's record.
Approval of the revised protocol for the post-approval study (PAS) protocol.
Source documents
Other decisions for Companion Spine France
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K253118 · Decided Dec 16, 2025 · 83 days after receipt
Device type: Manual Instruments Designed For Use With Non-Fusion Spinous Process Spacer Devices (QLR) · Orthopedic Surgery
1 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.